Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1371-1380

  Baranova, Irina N ^a   Vishnyakova, Tatyana G ^a   Bocharov, Alexander V ^a   Leelahavanichkul, Asada ^a,b   Kurlander, Roger ^a   Chen, Zhigang ^a   Souza, Ana C P ^a   Yuen, Peter S T ^a   Star, Robert A ^a   Csako, Gyorgy ^a   Patterson, Amy P ^a,c   Eggerman, Thomas L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CD36 ANTIGEN; CHAPERONIN; CLASS B SCAVENGER RECEPTOR 1; CLASS B SCAVENGER RECEPTOR 2; CORTICOSTERONE; CXCL1 CHEMOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MINERALOCORTICOID; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ARTICLE; BACTERIAL CELL WALL; BINDING SITE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENDOCYTOSIS; ESCHERICHIA COLI; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIGENS, CD36; BACTERIA; CHAPERONIN 60; CYTOKINES; ESCHERICHIA COLI; HELA CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION;

EID: 84863012767     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100350     Document Type: Article

References (70)

1. Podrez, E. A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277: 38517-38523. (Pubitemid 35154710)
2. Febbraio, M., E. A. Podrez, J. D. Smith, D. P. Hajjar, S. L. Hazen, H. F. Hoff, K. Sharma, and R. L. Silverstein. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105: 1049-1056. (Pubitemid 30217689)
3. Zhang, S., M. H. Picard, E. Vasile, Y. Zhu, R. L. Raffai, K. H. Weisgraber, and M. Krieger. 2005. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Circulation 111: 3457-3464. (Pubitemid 40923400)
4. Zhang, W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108: 2258-2263. (Pubitemid 37363044)
5. Van Eck, M., I. S. Bos, R. B. Hildebrand, B. T. Van Rij, and T. J. Van Berkel. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am. J. Pathol. 165: 785-794. (Pubitemid 39129286)
6. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
7. Cai, L., A. Ji, F. C. de Beer, L. R. Tannock, and D. R. van der Westhuyzen. 2008. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J. Clin. Invest. 118: 364-375.
8. Philips, J. A., E. J. Rubin, and N. Perrimon. 2005. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309: 1251-1253. (Pubitemid 41170920)
9. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. B. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485. (Pubitemid 41126946)
10. Vishnyakova, T. G., A. V. Bocharov, I. N. Baranova, Z. Chen, A. T. Remaley, G. Csako, T. L. Eggerman, and A. P. Patterson. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J. Biol. Chem. 278: 22771-22780. (Pubitemid 36830338)
11. Dawson, D. W., S. F. A. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier, and N. P. Bouck. 1997. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138: 707-717. (Pubitemid 27349849)
12. Barth, H., E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al. 2008. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol. 82: 3466-3479. (Pubitemid 351429922)
13. Bird, D. A., K. L. Gillotte, S. Hörkkö, P. Friedman, E. A. Dennis, J. L. Witztum, and D. Steinberg. 1999. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. USA 96: 6347-6352. (Pubitemid 29256668)
14. Ren, Y., R. L. Silverstein, J. Allen, and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181: 1857-1862.
15. Patel, H. H., F. Murray, and P. A. Insel. 2008. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 48: 359-391. (Pubitemid 351738158)
16. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009. (Pubitemid 24266467)
17. Murao, K., V. Terpstra, S. R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger. 1997. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272: 17551-17557. (Pubitemid 27311188)
18. Webb, N. R., P. M. Connell, G. A. Graf, E. J. Smart, W. J. de Villiers, F. C. de Beer, and D. R. van der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248. (Pubitemid 28272825)
19. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985. (Pubitemid 27373951)
20. Eckhardt, E. R. M., L. Cai, B. Sun, N. R. Webb, and D. R. van der Westhuyzen. 2004. High density lipoprotein uptake by scavenger receptor SR-BII. J. Biol. Chem. 279: 14372-14381. (Pubitemid 38468979)
21. Abumrad, N. A., M. R. el-Maghrabi, E. Z. Amri, E. Lopez, and P. A. Grimaldi. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: homology with human CD36. J. Biol. Chem. 268: 17665-17668. (Pubitemid 23260267)
22. Kuchibhotla, S., D. Vanegas, D. J. Kennedy, E. Guy, G. Nimako, R. E. Morton, and M. Febbraio. 2008. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc. Res. 78: 185-196. (Pubitemid 351430949)
23. Silverstein, R. L. 2009. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve. Clin. J. Med. 76(Suppl. 2): S27-S30.
24. Zhang, X., R. L. Fitzsimmons, L. G. Cleland, P. L. Ey, A. C. Zannettino, E. A. Farmer, P. Sincock, and G. Mayrhofer. 2003. CD36/fatty acid translocase in rats: distribution, isolation from hepatocytes, and comparison with the scavenger receptor SR-B1. Lab. Invest. 83: 317-332. (Pubitemid 36350994)
25. Baranova, I. N., R. Kurlander, A. V. Bocharov, T. G. Vishnyakova, Z. Chen, A. T. Remaley, G. Csako, A. P. Patterson, and T. L. Eggerman. 2008. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol. 181: 7147-7156.
26. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527. (Pubitemid 40204309)
27. Triantafilou, M., F. G. Gamper, P. M. Lepper, M. A. Mouratis, C. Schumann, E. Harokopakis, R. E. Schifferle, G. Hajishengallis, and K. Triantafilou. 2007. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2- induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol. 9: 2030-2039. (Pubitemid 47087093)
28. Bocharov, A. V., I. N. Baranova, T. G. Vishnyakova, A. T. Remaley, G. Csako, F. Thomas, A. P. Patterson, and T. L. Eggerman. 2004. Targeting of scavenger receptor class B type I by synthetic amphipathic α-helical- containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J. Biol. Chem. 279: 36072-36082. (Pubitemid 39100615)
29. Galdiero, M., G. C. de l'Ero, and A. Marcatili. 1997. Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. Infect. Immun. 65: 699-707. (Pubitemid 27053983)
30. Tabona, P., K. Reddi, S. Khan, S. P. Nair, S. J. Crean, S. Meghji, M. Wilson, M. Preuss, A. D. Miller, S. Poole, et al. 1998. Homogeneous Escherichia coli chaperonin 60 induces IL-1 β and IL-6 gene expression in human monocytes by a mechanism independent of protein conformation. J. Immunol. 161: 1414-1421. (Pubitemid 28380571)
31. Friedland, J. S., R. Shattock, D. G. Remick, and G. E. Griffin. 1993. Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin. Exp. Immunol. 91: 58-62. (Pubitemid 23027998)
32. Kol, A., T. Bourcier, A. H. Lichtman, and P. Libby. 1999. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103: 571-577. (Pubitemid 29094058)
33. Wagner, M., I. Hermanns, F. Bittinger, and C. J. Kirkpatrick. 1999. Induction of stress proteins in human endothelial cells by heavy metal ions and heat shock. Am. J. Physiol. 277: L1026-L1033.
34. Trautinger, F., I. Kindås-Mügge, R. M. Knobler, and H. Hönigsmann. 1996. Stress proteins in the cellular response to ultraviolet radiation. J. Photochem. Photobiol. B 35: 141-148. (Pubitemid 26383614)
35. Kol, A., A. H. Lichtman, R. W. Finberg, P. Libby, and E. A. Kurt-Jones. 2000. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164: 13-17. (Pubitemid 30012965)
36. Bethke, K., F. Staib, M. Distler, U. Schmitt, H. Jonuleit, A. H. Enk, P. R. Galle, and M. Heike. 2002. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J. Immunol. 169: 6141-6148. (Pubitemid 36903458)
37. Hu, Y., B. Henderson, P. A. Lund, P. Tormay, M. T. Ahmed, S. S. Gurcha, G. S. Besra, and A. R. Coates. 2008. A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection. Infect. Immun. 76: 1535-1546. (Pubitemid 351561997)
38. Osterloh, A., F. Geisinger, M. Piédavent, B. Fleischer, N. Brattig, and M. Breloer. 2009. Heat shock protein 60 (HSP60) stimulates neutrophil effector functions. J. Leukoc. Biol. 86: 423-434.
39. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274: 17406-17409.
40. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1-5. (Pubitemid 29295815)
41. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376. (Pubitemid 37174535)
42. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
43. Beutler, B., X. Du, and A. Poltorak. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin Res. 7: 277-280. (Pubitemid 33041064)
44. Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Häcker, and H. Wagner. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276: 31332-31339. (Pubitemid 37385004)
45. Ohashi, K., V. Burkart, S. Flohé, and H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164: 558-561. (Pubitemid 30043672)
46. Sasu, S., D. LaVerda, N. Qureshi, D. T. Golenbock, and D. Beasley. 2001. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/ p42 mitogen-activated protein kinase activation. Circ. Res. 89: 244-250. (Pubitemid 34132682)
47. Lewthwaite, J. C., A. R. Coates, P. Tormay, M. Singh, P. Mascagni, S. Poole, M. Roberts, L. Sharp, and B. Henderson. 2001. Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain. Infect. Immun. 69: 7349-7355. (Pubitemid 33086558)
48. Takenaka, R., K. Yokota, K. Ayada, M. Mizuno, Y. Zhao, Y. Fujinami, S.-N. Lin, T. Toyokawa, H. Okada, Y. Shiratori, and K. Oguma. 2004. Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 150: 3913-3922. (Pubitemid 40045322)
49. Habich, C., K. Baumgart, H. Kolb, and V. Burkart. 2002. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol. 168: 569-576. (Pubitemid 34049555)
50. Habich, C., and V. Burkart. 2007. Heat shock protein 60: regulatory role on innate immune cells. Cell. Mol. Life Sci. 64: 742-751. (Pubitemid 46474983)
51. Osterloh, A., A. Veit, A. Gessner, B. Fleischer, and M. Breloer. 2008. Hsp60- mediated T cell stimulation is independent of TLR4 and IL-12. Int. Immunol. 20: 433-443. (Pubitemid 351321251)
52. Henderson, B., and J. Mesher. 2007. The search for the chaperonin 60 receptors. Methods 43: 223-228. (Pubitemid 47499076)
53. Asea, A., S. K. Kraeft, E. A. Kurt-Jones, M. A. Stevenson, L. B. Chen, R. W. Finberg, G. C. Koo, and S. K. Calderwood. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6: 435-442. (Pubitemid 30208161)
54. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112. (Pubitemid 34952589)
55. Vabulas, R. M., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C. J. Kirschning, C. Da Costa, H. G. Rammensee, H.Wagner, and H. Schild. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277: 20847-20853. (Pubitemid 34967392)
56. Murphy, J. E., P. R. Tedbury, S. Homer-Vanniasinkam, J. H. Walker, and S. Ponnambalam. 2005. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182: 1-15. (Pubitemid 41188365)
57. Merrifield, R. B. 1969. The synthesis of biologically active peptides and proteins. JAMA 210: 1247-1254.
58. Fairwell, T., A. V. Hospattankar, H. B. Brewer, Jr., and S. A. Khan. 1987. Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization. Proc. Natl. Acad. Sci. USA 84: 4796-4800. (Pubitemid 17095838)
59. Kurt-Jones, E. A., F. Sandor, Y. Ortiz, G. N. Bowen, S. L. Counter, T. C. Wang, and R. W. Finberg. 2004. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J. Endotoxin Res. 10: 419-424. (Pubitemid 39618557)
60. Eyre, N. S., L. G. Cleland, N. N. Tandon, and G. Mayrhofer. 2007. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J. Lipid Res. 48: 528-542. (Pubitemid 46397457)
61. Baranova, I. N., A. V. Bocharov, T. G. Vishnyakova, R. Kurlander, Z. Chen, D. Fu, I. M. Arias, G. Csako, A. P. Patterson, and T. L. Eggerman. 2010. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J. Biol. Chem. 285: 8492-8506.
62. Williams, D. L., M. de La Llera-Moya, S. T. Thuahnai, S. Lund-Katz, M. A. Connelly, S. Azhar, G. M. Anantharamaiah, and M. C. Phillips. 2000. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. J. Biol. Chem. 275: 18897-18904. (Pubitemid 30422853)
63. Hoekstra, M., D. Ye, R. B. Hildebrand, Y. Zhao, B. Lammers, M. Stitzinger, J. Kuiper, T. J. Van Berkel, and M. Van Eck. 2009. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J. Lipid Res. 50: 1039-1046.
64. Bentley, P. J. 1980. Endocrine Pharmacology: Physiological Basis and Therapeutic Applications. Cambridge University Press, New York, p. 154.
65. Guo, L., Z. Song, M. Li, Q. Wu, D. Wang, H. Feng, P. Bernard, A. Daugherty, B. Huang, and X. A. Li. 2009. Scavenger Receptor BI protects against septic death through its role in modulating inflammatory response. J. Biol. Chem. 284: 19826-19834.
66. Vishnyakova, T. G., R. Kurlander, A. V. Bocharov, I. N. Baranova, Z. Chen, M. S. Abu-Asab, M. Tsokos, D. Malide, F. Basso, A. T. Remaley, et al. 2006. CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proc. Natl. Acad. Sci. USA 103: 16888-16893. (Pubitemid 44737348)
67. Means, T. K., E. Mylonakis, E. Tampakakis, R. A. Colvin, E. Seung, L. Puckett, M. F. Tai, C. R. Stewart, R. Pukkila-Worley, S. E. Hickman, et al. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206: 637-653.
68. Triantafilou, M., F. G. J. Gamper, R. M. Haston, M. A. Mouratis, S. Morath, T. Hartung, and K. Triantafilou. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002-31011. (Pubitemid 44582155)
69. Gon, Y., Y. Asai, S. Hashimoto, K. Mizumura, I. Jibiki, T. Machino, C. Ra, and T. Horie. 2004. A20 inhibits Toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 31: 330-336. (Pubitemid 39180303)
70. Annane, D., V. Sébille, C. Charpentier, P. E. Bollaert, B. François, J. M. Korach, G. Capellier, Y. Cohen, E. Azoulay, G. Troché, et al. 2002. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871.